Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Reece

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Scientific Reports|August 20, 2017
NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humansMartin Gengenbacher, Maria A Duque-Correa, Peggy Kaiser, et al.
European Journal of Immunology|May 1, 2014
Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamicsAnca Dorhoi, Vladimir Yeremeev, Geraldine Nouailles, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2014
Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomasMaría A Duque-Correa, Anja A Kühl, Paulo C Rodriguez, et al.
NPJ Vaccines|July 4, 2025
Intranasal delivery of mRNA expressing newly identified Acinetobacter baumannii antigens protects against bacterial lung diseaseSophie L Higham, Ziyin Wang, Valarmathy Murugaiah, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosyJohn S Spencer, Hee Jin Kim, William H Wheat, et al.
Clinical and Vaccine Immunology : CVI|September 28, 2007
Use of protein antigens for early serological diagnosis of leprosyMalcolm S Duthie, Wakako Goto, Greg C Ireton, et al.
Clinical and Vaccine Immunology : CVI|January 30, 2009
From genome-based in silico predictions to ex vivo verification of leprosy diagnosisAnnemieke Geluk, John S Spencer, Kidist Bobosha, et al.
Nature Communications|September 12, 2024
Exploiting human immune repertoire transgenic mice for protective monoclonal antibodies against antimicrobial resistant Acinetobacter baumanniiStephen Baker, Aishwarya Krishna, Sophie Higham, et al.
The Lancet. Microbe|June 8, 2021
Detection of <i>Mycobacterium tuberculosis</i> complex DNA in CD34-positive peripheral blood mononuclear cells of asymptomatic tuberculosis contacts: an observational studyMulugeta Belay, Begna Tulu, Sidra Younis, et al.
Immunity|June 12, 2026
Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protectionBarnabas G Williams, Jordan R Barrett, Josefin Bartholdson Scott, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Scientific Reports|August 20, 2017
NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humansMartin Gengenbacher, Maria A Duque-Correa, Peggy Kaiser, et al.
European Journal of Immunology|May 1, 2014
Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamicsAnca Dorhoi, Vladimir Yeremeev, Geraldine Nouailles, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2014
Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomasMaría A Duque-Correa, Anja A Kühl, Paulo C Rodriguez, et al.
NPJ Vaccines|July 4, 2025
Intranasal delivery of mRNA expressing newly identified Acinetobacter baumannii antigens protects against bacterial lung diseaseSophie L Higham, Ziyin Wang, Valarmathy Murugaiah, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosyJohn S Spencer, Hee Jin Kim, William H Wheat, et al.
Clinical and Vaccine Immunology : CVI|September 28, 2007
Use of protein antigens for early serological diagnosis of leprosyMalcolm S Duthie, Wakako Goto, Greg C Ireton, et al.
Clinical and Vaccine Immunology : CVI|January 30, 2009
From genome-based in silico predictions to ex vivo verification of leprosy diagnosisAnnemieke Geluk, John S Spencer, Kidist Bobosha, et al.
Nature Communications|September 12, 2024
Exploiting human immune repertoire transgenic mice for protective monoclonal antibodies against antimicrobial resistant Acinetobacter baumanniiStephen Baker, Aishwarya Krishna, Sophie Higham, et al.
The Lancet. Microbe|June 8, 2021
Detection of <i>Mycobacterium tuberculosis</i> complex DNA in CD34-positive peripheral blood mononuclear cells of asymptomatic tuberculosis contacts: an observational studyMulugeta Belay, Begna Tulu, Sidra Younis, et al.
Immunity|June 12, 2026
Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protectionBarnabas G Williams, Jordan R Barrett, Josefin Bartholdson Scott, et al.
Pageof 7